Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

EHA 2015 | Improving outcomes in elderly patients with cancer

Matti Aapro • 12 Jun 2015
EHA 2015
Hodgkin Lymphoma Multiple Myeloma Non-Hodgkin Lymphoma

Cancer is a prevalent disease in elderly patients. At the 20th Congress of the European Hematology Association (EHA), Matti Aapro, MD, of Clinique de Genolier, Genolier, Switzerland, discusses some of the challenges in geriatric oncology research and the development of effective therapies for this patient population.

More from Matti Aapro

5:06
Considerations for drug development in hematological oncology
Matti Aapro • 12 Jun 2015

Related Videos

5:56
Phase Ib shows pembrolizumab elicits complete or partial remission in Hodgkin lymphoma
Craig Moskowitz • 9 Apr 2015
1:54
The future of multiple myeloma treatment
Gareth Morgan • 26 Feb 2016
2:10
Overview of a Phase II clinical trial of isatuximab
Joseph Mikhael • 29 Jan 2016
7:15
ENDEAVOUR, ASPIRE and TOURMALINE-MM1 trial results for multiple myeloma
Michel Delforge • 26 May 2016
The content of VJHemOnc is intended for healthcare professionals